Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
Cassandra Aldrich, Isabel Leroux‐Roels, Katell Bidet Huang, Mihai Alexandru Bica, Edde Loeliger, Oliver Schönborn‐Kellenberger, Lisa Walz, Geert Leroux‐Roels, Frank von Sonnenburg, Lidia Oostvogels
Topics & Concepts
ReactogenicityMedicineImmunogenicityRabies vaccineRabiesVaccinationTiterAdverse effectRabies virusNeutralizing antibodyImmune systemPharmacologyVirologyImmunologyVirusRabies epidemiology and controlViral Infections and Outbreaks ResearchVirology and Viral Diseases